204 related articles for article (PubMed ID: 8037209)
1. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.
Sherman JB; Raben N; Nicastri C; Argov Z; Nakajima H; Adams EM; Eng CM; Cowan TM; Plotz PH
Am J Hum Genet; 1994 Aug; 55(2):305-13. PubMed ID: 8037209
[TBL] [Abstract][Full Text] [Related]
2. Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease.
Vasconcelos O; Sivakumar K; Dalakas MC; Quezado M; Nagle J; Leon-Monzon M; Dubnick M; Gajdusek DC; Goldfarb LG
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10322-6. PubMed ID: 7479776
[TBL] [Abstract][Full Text] [Related]
3. Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
Raben N; Sherman JB; Adams E; Nakajima H; Argov Z; Plotz P
Muscle Nerve Suppl; 1995; 3():S35-8. PubMed ID: 7603525
[TBL] [Abstract][Full Text] [Related]
4. A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease).
Raben N; Sherman J; Miller F; Mena H; Plotz P
J Biol Chem; 1993 Mar; 268(7):4963-7. PubMed ID: 8444874
[TBL] [Abstract][Full Text] [Related]
5. Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation.
Sivakumar K; Vasconcelos O; Goldfarb L; Dalakas MC
Neurology; 1996 May; 46(5):1337-42. PubMed ID: 8628478
[TBL] [Abstract][Full Text] [Related]
6. Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions.
Nichols RC; Rudolphi O; Ek B; Exelbert R; Plotz PH; Raben N
Am J Hum Genet; 1996 Jul; 59(1):59-65. PubMed ID: 8659544
[TBL] [Abstract][Full Text] [Related]
7. Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency.
Tsujino S; Servidei S; Tonin P; Shanske S; Azan G; DiMauro S
Am J Hum Genet; 1994 May; 54(5):812-9. PubMed ID: 7513946
[TBL] [Abstract][Full Text] [Related]
8. Mutations in muscle phosphofructokinase gene.
Raben N; Sherman JB
Hum Mutat; 1995; 6(1):1-6. PubMed ID: 7550225
[TBL] [Abstract][Full Text] [Related]
9. Muscle phosphofructokinase deficiency in two generations.
Vorgerd M; Karitzky J; Ristow M; Van Schaftingen E; Tegenthoff M; Jerusalem F; Malin JP
J Neurol Sci; 1996 Sep; 141(1-2):95-9. PubMed ID: 8880699
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.
Raben N; Exelbert R; Spiegel R; Sherman JB; Nakajima H; Plotz P; Heinisch J
Am J Hum Genet; 1995 Jan; 56(1):131-41. PubMed ID: 7825568
[TBL] [Abstract][Full Text] [Related]
11. Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5'-splice site.
Nakajima H; Kono N; Yamasaki T; Hotta K; Kawachi M; Kuwajima M; Noguchi T; Tanaka T; Tarui S
J Biol Chem; 1990 Jun; 265(16):9392-5. PubMed ID: 2140573
[TBL] [Abstract][Full Text] [Related]
12. Late-onset muscular weakness in phosphofructokinase deficiency due to exon 5/intron 5 junction point mutation: a unique disorder or the natural course of this glycolytic disorder?
Argov Z; Barash V; Soffer D; Sherman J; Raben N
Neurology; 1994 Jun; 44(6):1097-100. PubMed ID: 8208408
[TBL] [Abstract][Full Text] [Related]
13. Novel missense mutation (W686C) of the phosphofructokinase-M gene in a Japanese patient with a mild form of glycogenosis VII.
Hamaguchi T; Nakajima H; Noguchi T; Nakagawa C; Kuwajima M; Kono N; Tarui S; Matsuzawa Y
Hum Mutat; 1996; 8(3):273-5. PubMed ID: 8889589
[No Abstract] [Full Text] [Related]
14. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF
Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809
[TBL] [Abstract][Full Text] [Related]
15. Canavan disease: mutations among Jewish and non-Jewish patients.
Kaul R; Gao GP; Aloya M; Balamurugan K; Petrosky A; Michals K; Matalon R
Am J Hum Genet; 1994 Jul; 55(1):34-41. PubMed ID: 8023850
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.
Vora S; Davidson M; Seaman C; Miranda AF; Noble NA; Tanaka KR; Frenkel EP; Dimauro S
J Clin Invest; 1983 Dec; 72(6):1995-2006. PubMed ID: 6227635
[TBL] [Abstract][Full Text] [Related]
17. Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.
Edelmann L; Wasserstein MP; Kornreich R; Sansaricq C; Snyderman SE; Diaz GA
Am J Hum Genet; 2001 Oct; 69(4):863-8. PubMed ID: 11509994
[TBL] [Abstract][Full Text] [Related]
18. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.
Whitney MA; Saito H; Jakobs PM; Gibson RA; Moses RE; Grompe M
Nat Genet; 1993 Jun; 4(2):202-5. PubMed ID: 8348157
[TBL] [Abstract][Full Text] [Related]
19. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
Roa BB; Savino CV; Richards CS
Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis in Jews: frequency and mutation distribution.
Kerem B; Chiba-Falek O; Kerem E
Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
